Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Factor VII Antikörper (AA 366-466)

Der Maus Monoklonal anti-Factor VII Antikörper (Klon F7-3618) (ABIN7862776) detektiert spezifisch Factor VII in IHC und ELISA. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7862776
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Factor VII Antikörper (AA 366-466) (ABIN7862776)

Target

Alle Factor VII (F7) Antikörper anzeigen
Factor VII (F7) (Coagulation Factor VII (F7))

Reaktivität

  • 96
  • 14
  • 9
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 62
  • 40
  • 9
  • 2
  • 1
Maus

Klonalität

  • 75
  • 39
Monoklonal

Konjugat

  • 86
  • 15
  • 5
  • 4
  • 2
  • 1
  • 1
Dieser Factor VII Antikörper ist unkonjugiert

Applikation

  • 66
  • 54
  • 44
  • 18
  • 17
  • 17
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Klon

F7-3618
  • Bindungsspezifität

    • 27
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 366-466

    Verwendungszweck

    Coagulation Factor VII / F7 Antibody

    Spezifität

    Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin and Factors X, IX, V and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble Fibrin clots and the promotion of platelet aggregation. Coagulation Factor VII (serum prothrombin conversion accelerator, proconvertin, F7, Factor VII) is a 406 amino acid, vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor. Factor IX A, Factor X A, Factor XII A or Thrombin-mediated proteolytic cleavage of Factor VII at Arg 152-Ile 153 generates Factor VII A, an active serine protease composed of a catalytic heavy chain disulfide linked to a light chain, containing two EGF-like domains. Mutations at the F7 locus that lead to Factor VII deficiencies are generally asymptomatic or phenotypically uncharacterized, with hemorrhagic diathesis occurring at extremely low levels.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 366-466) of human F7 protein

    Isotyp

    IgG2b, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    Factor VII (F7) (Coagulation Factor VII (F7))

    Andere Bezeichnung

    Coagulation Factor VII

    Hintergrund

    Eptacog alfa, Factor VII heavy chain, Factor VII light chain, FVII coagulation protein, Proconvertin, Serum prothrombin conversion accelerator (SPCA)

    Human liver or gastric carcinoma.

    Molekulargewicht

    200/80/73/50/43 kDa

    Gen-ID

    2155, 36989

    UniProt

    P08709

    Pathways

    Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Sie sind hier:
Chat with us!